Aspro Neil Martinson

Neil Martinson is a South African clinician-scientist widely recognized for leadership in HIV and tuberculosis research, with longstanding affiliation to the University of the Witwatersrand and major public health research units in Soweto. His work centers on improving outcomes for vulnerable populations through pragmatic clinical trials, cohort studies, and community-based interventions.

Research spans multidrug-resistant tuberculosis prevention in children, TB diagnostics, HIV-associated malignancies, and integrated approaches to respiratory infections including influenza, RSV, and COVID-19. He has led landmark trials on levofloxacin preventive therapy and innovative strategies for post-hospital HIV care, advancing evidence for policy and practice in high-burden settings.

Martinson’s scholarship emphasizes implementation science, vaccine trial platforms, and geographically informed disease surveillance. Across diverse studies, a consistent strength is translating rigorous epidemiology and randomized evidence into scalable interventions that address TB, HIV, and respiratory disease morbidity and mortality in resource-limited communities.